Skip to content

Sobrefluid Rinoneb Nebulizzatore

by Adl Farmaceutici SRL EUDAMED

Withdrawn No longer placed on the EU market

Ref ADL-D137Model SOBREFLUID RINONEB NEBULIZZATORE

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number8053306780206YF Basic UDI-DIDate9 Jan 2026RegisteredStatusWithdrawn No longer placed on the EU market

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/MDR Withdrawn

Certificates: none listed in EUDAMED

Specification

EUDAMED

Device Name
Sobrefluid Rinoneb
Model / Reference
SOBREFLUID RINONEB NEBULIZZATORE, ADL-D137
Primary DI / UDI-DI
08053306780536
Basic UDI-DI
8053306780206YF
EMDN Code
Q030199 Nasopharyngeal devices - other
Device Class
Class I
Market of Registration
Italy

Manufacturer details

EUDAMED SRN
IT-MF-000037063

Other devices from Adl Farmaceutici SRL

See all devices from Adl Farmaceutici SRL →

Properties

Other properties (13)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No